After building around the margins last offseason, the Chargers are positioned to make a splash in Jim Harbaugh's second ...
WASHINGTON, DC - JANUARY 20: Apple CEO Tim Cook (C) sits next to Donald Trump Jr at the inaugural ... [+] luncheon on January 20, 2025 in Washington, DC. Donald Trump takes office for his second ...
(This story was updated to add information about the incident.) The Simi Valley Police Department’s SWAT team went to a mobile home park in the city Sunday to talk a man believed to have fired a ...
Shelby Knowles / Bloomberg via Getty Images Eli Lilly's Zepbound can be covered by Medicare Part D plans after the FDA approved the drug as a treatment for sleep apnea last month. Weight loss ...
Shares of Eli Lilly have been falling in recent months, but that could spell opportunity. Investors appear to be concerned that a new government could impact its growth potential. The business is ...
Tim Smith has 20+ years of experience in the financial services industry, both as a writer and as a trader. Eli Lilly shares could remain under the microscope on Wednesday after falling sharply ...
What will Eli Lilly do with all its cash from Mounjaro and Zepbound? What does CEO Dave Ricks think it would take for the company to reach a $1 trillion market capitalization? And how does Ricks ...
Employees are advised to complete this process promptly to access benefits under the Employment Linked Incentive (ELI) scheme. Why UAN activation is important? UAN, a unique 12-digit identifier ...
Eli Lilly and Co. LLY Eli Lilly’s shares fell 6.59%, closing at $744.91. The stock had an intraday high of $784.23 and a low of $729, with a 52-week range of $612.7 to $972.53. The company ...
Eli Lilly (NYSE:LLY) shares sold off on Tuesday after the Indiana-based pharma giant's Q4 and 2024 preliminary sales results for its obesity therapy tirzepatide fell short of Street forecasts ...
Investing.com -- Eli Lilly and Company (NYSE:LLY) has projected its full-year global revenue for 2024 to reach around $45 billion, marking a 32% increase from the prior year. The company also ...
Eli Lilly (LLY) shares traded down more than 6% Tuesday after the company reported revenue guidance for the fourth quarter of 2024 that missed Wall Street expectations. Lilly revised its revenue ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results